The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.
You can find a full list of media coverage about MFICM on the News page
Who has been invited to co-lead the Pan-Cancer and Molecular Oncology Community at Genomics England.
To use AI to personalise ovarian cancer treatment
Sarah speaks to the Cambridge Independent and BBC Radio Cambridgeshire about how the Cambridge Zenith AI Supercomputer will help cancer research and deliver on the ambition of the Cambridge Cancer Research Hospital.
Thursday 9 July 2026, 12:00 -13:00 at the Jeffrey Cheah Biomedical Centre, Main Lecture Theatre.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
